CoChat

Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities

Open access
Cogswell, Petrice M., Andrews, Trevor J., Barakos, Jerome A., Barkhof, Frederik, Bash, Suzie, Benayoun, Marc Daniel, Chiang, Gloria C., Franceschi, Ana M., Jack, Clifford R., Pillai, Jay J., Poussaint, Tina Young, Raji, Cyrus A., Ramanan, Vijay K., Tanabe, Jody, Tanenbaum, Lawrence, Whitlow, Christopher T., Yu, Fang F., Zaharchuk, Greg, Zeinah, Michael, Benzinger, Tammie S. · 2025 · American Journal of Neuroradiology
Cited by 93

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

With full FDA approval and Centers for Medicare & Medicaid Services coverage of lecanemab and donanemab, a growing number of practices are offering anti-amyloid immunotherapy to appropriate patients with cognitive impairment or mild dementia due to amyloid-positive Alzheimer disease. The goal of this article is to provide updated practical considerations for radiologists, including implementation of MR imaging protocols, workflows, and reporting and communication practices relevant to anti-amyloid immunotherapy and monitoring for amyloid-related imaging abnormalities (ARIA). On the basis of consensus discussion within an expanded American Society of Neuroradiology (ASNR) Alzheimer, ARIA, and Dementia Study Group, our purpose is the following: 1) summarize the FDA guidelines for the evaluation of radiographic ARIA; 2) review the 3 key MRI sequences for ARIA monitoring and standardized imaging protocols on the basis of ASNR-industry collaborations; 3) provide imaging recommendations for 3 key patient scenarios; 4) highlight the role of the radiologist in the care team for this population; 5) discuss implementation of MRI protocols to detect ARIA in diverse practice settings; and 6) present the results of the 2023 ASNR international neuroradiologist practice survey on dementia and ARIA imaging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3174/ajnr.a8469

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 93

Metadata

Authors
Cogswell, P. M., Andrews, T. J., Barakos, J. A., Barkhof, F., Bash, S., Benayoun, M. D., Chiang, G. C., Franceschi, A. M., Jack, C. R., Pillai, J. J., Poussaint, T. Y., Raji, C. A., Ramanan, V. K., Tanabe, J., Tanenbaum, L., Whitlow, C. T., Yu, F. F., Zaharchuk, G., Zeinah, M., & Benzinger, T. S.
Venue
American Journal of Neuroradiology
Published
2024-08-23
Volume
46
Issue
1
Pages
24-32
ISSN
  • 0195-6108 (ISSN-L)
  • 1936-959X
OpenAlex
W4401811647
Cited by
93
References
13
FWCI
22.00
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities. https://app.cochat.ai/papers/10.3174/ajnr.a8469
The paper
Cogswell, P. M., Andrews, T. J., Barakos, J. A., Barkhof, F., Bash, S., Benayoun, M. D., Chiang, G. C., Franceschi, A. M., Jack, C. R., Pillai, J. J., Poussaint, T. Y., Raji, C. A., Ramanan, V. K., Tanabe, J., Tanenbaum, L., Whitlow, C. T., Yu, F. F., Zaharchuk, G., Zeinah, M., & Benzinger, T. S. (2025). Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities. American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.a8469

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.